Nika Pharmaceuticals, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OQB
Dimitar Slavchev Savov, CEO, CFO, and President of NIKA Pharmaceuticals, purchased 2,000,000 shares of common stock at $0.25 per share on March 18, 2025.
OQB
NIKA Pharmaceuticals, Inc. reports the acquisition of 145,000,000 shares of common stock by a 10% owner through an LLC.
OQB
Form 4: NIKA Pharmaceuticals, Inc.: NIKA PHARMACEUTICALS, INC Reports Changes in Beneficial Ownership
NIKA PHARMACEUTICALS, INC reports transactions involving preferred and common stock, including acquisitions, disposals, and a forward stock split.